NY-BCW
8.10.2018 23:15:10 CEST | Business Wire | Press release
BCW (Burson Cohn & Wolfe), a leading global communications agency, today announced the addition of top public affairs and technology experts to its U.S. team: Terry Neal has joined the firm as Executive Vice President, Managing Director, Public Affairs and James Cook has joined as Executive Vice President, Managing Director, New York Technology. Neal is based in Washington, D.C. and Cook is based in New York.
“Terry and James represent the high caliber of talent that BCW attracts, which makes us such a powerful partner to our clients,” said Chris Foster, President, North America, BCW. “Both Terry and James are world-class counselors with deep experience working with Fortune 100 clients and developing integrated communications solutions that make an impact on clients’ bottom lines. I am confident that Terry’s background in journalism and his expertise in advising on policy and regulatory matters, and James’s global perspective and track record in building business, will be of enormous value to our clients.”
Neal has more than two decades of experience in media, advocacy and strategic communications, managing multi-platform campaigns for clients spanning the automotive, consultancy, energy, financial and technology industries. He also is a veteran crisis counselor, having advised government agencies and sovereign nations on their communications needs. Before joining BCW, he ran his own consultancy, Neal Communication Strategies, LLC, and served with The Podesta Group, Fannie Mae, CGI Federal, Light Squared and Hill + Knowlton Strategies. Neal began his career in the media, as a national political reporter, columnist and editor at The Washington Post, Miami Herald and Fort Lauderdale Sun-Sentinel. As a newspaper reporter, Neal had more than 2,000 published bylines and more than 200 television appearances across CNN, MSNBC, NBC and PBS.
Cook has more than 20 years of experience working both in agencies and in-house, creating and implementing integrated communications strategies for consumer, corporate and technology companies ranging from early stage start-ups to large multinationals. He has extensive expertise in devising, planning and implementing global, North America, Asia, UK and pan-European communications campaigns, including management and coordination of a network of global / regional agencies. Cook joined BCW from Edelman where he led Revere NY, Edelman’s in-house technology boutique, where he doubled revenue in one year. Cook also led the Artificial Intelligence Center of Excellence in Edelman’s New York office. Before that he spent eight years with Edelman in Beijing and Singapore, running their respective technology practices. Earlier in his career he held senior roles with MSL in Toronto and Weber Shandwick in Beijing, Toronto and London driving double-digit revenue growth in each role.
About BCW
BCW is one of the world’s largest full-service global communications agencies. Founded by the merger of Burson-Marsteller and Cohn & Wolfe, BCW delivers digitally and data-driven creative content and integrated communications programs grounded in earned media and scaled across all channels for clients in the B2B, consumer, corporate, crisis management, CSR, healthcare, public affairs and technology sectors. BCW is a part of WPP (NYSE: WPP), the world's leader in communications services. For more information, visit www.bcw-global.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20181008005786/en/
Contact:
Media Contact: BCW Catherine Sullivan, 212-798-9501 Catherine.Sullivan@bm.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Integrated Hubs for Green Chemistry Research Aim to Transform How Chemicals and Materials Are Designed12.11.2026 17:00:00 CET | Press release
International network will investigate fundamental principles for creating safer, higher-performing chemicals and materials The Gordon and Betty Moore Foundation today announced four Integrated Research Hubs to explore new frontiers in chemical design, from materials that respond to their surroundings to molecules designed for safety from the start. Bringing together global researchers across institutions and disciplines, the hubs will investigate fundamental principles that could enable new capabilities in chemicals and materials while improving performance and protecting human health and the environment. The research priorities emerged through extensive engagement with the scientific community to identify the questions that could transform what chemistry can achieve. Each hub will connect researchers across institutions around one of four green chemistry focus areas: Safer molecular design: Led by The George Washington University, this hub will combine artificial intelligence and qua
Roquette Highlights Scalable Excipient and Capsule Solutions for Regional and Global Pharmaceutical Markets at CPHI India 202612.11.2026 16:00:00 CET | Press release
Helping pharmaceutical manufacturers accelerate the journey from formulation to market through deep technical expertise, meaningful innovation, close collaboration and global capabilities Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical excipients, will showcase its comprehensive portfolio of excipient and capsule solutions at CPHI India 2026, Hall 1, Booth 1I12 from November 23 to 25, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112803410/en/ Meet Roquette at CPHI India 2026, Hall 1, Booth 1I12 At the event, Roquette will demonstrate how it helps pharmaceutical manufacturers accelerate the journey from formulation to market with confidence. By combining technical expertise, trusted quality, meaningful innovation and close collaboration, Roquette helps customers address formulation, scale-up and manufacturing challenges across a broad range of pharmaceutical application
Tigo Energy and Google Cloud Pair AI-Powered Tools for Solar Installers and Utilities12.11.2026 15:00:00 CET | Press release
The collaboration combines Tigo software with Google’s Gemini models on Google Cloud to help automate installer and utility operations for distributed energy portfolios. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy software solutions, today announced a collaboration with Google Cloud to develop AI-enabled operational workflows for solar installers and distributed energy portfolios. By making core Tigo data and software products available through Google Cloud, Tigo aims to deliver faster deployment, simplified data integration, and additional insights with Gemini. The resulting workflows will help installers, asset managers, and energy operators more easily identify issues, prioritize actions, and automate routine operational tasks across growing fleets of distributed energy systems. As solar and storage portfolios expand, energy businesses are increasingly responsible for managing more sites, more system data, and more custo
Patsnap Releases State of Pharma Intelligence 2026 Report, Reveals Pharma's Cautious Embrace of AI in Decision-Making12.11.2026 15:00:00 CET | Press release
A new survey of 130 senior life sciences leaders on AI in pharma R&D and competitive intelligence finds that 92% can name a recent R&D, portfolio, or partnership decision where AI changed the outcome. Patsnap, the AI-native innovation intelligence company for IP and R&D teams, today released "State of Pharma Intelligence 2026: The Confidence to Act", a benchmark report on how pharma teams use and trust AI in R&D, competitive intelligence and business development decisions. The report draws on responses from 130 senior leaders at Director level or above across the United States, the United Kingdom, Germany, Switzerland, and France, spanning drug developers, CDMOs/CMOs, CROs, and consulting and professional services firms. The survey was fielded in August 2026 in partnership with NewtonX. Patsnap commissioned the research to understand how AI is influencing decisions across pharma R&D and business development, what builds confidence in its output, and where intelligence workflows fall sh
REPLY: the Board of Directors Approves the Quarterly Financial Report as of 30 September 202612.11.2026 14:41:00 CET | Press release
All economic indicators have substantially improved:Consolidated turnover of €1,987.9 million (1,819.8 as at 30 September 2025)EBITDA of €354.9 million (335.5 as at 30 September 2025)EBIT of €286.7 million (281.0 as at 30 September 2025)Pre-tax profit of €291.6 million (268.1 as at 30 September 2025)Positive Net Financial Position of €397.0 million. Today, the Board of Directors of Reply [EXM, STAR: REY] approved the results as at 30 September 2026. The Group's consolidated turnover in the first nine months of the year reached €1,987.9 million, an increase of 9.2% compared to €1,819.8 million recorded on 30 September 2025. The indicators for the period are positive. Consolidated EBITDA was €354.9 million, equal to 17.9% of the consolidated revenues. As of September 2025 EBITDA was €335.5 million. EBIT, from January to September, reached €286.7 million, equal to 14.4% of the consolidated revenues. The corresponding 2025 figure was €281.0 million. Pre-tax profit, from January to Septembe
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
